Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.46 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.46 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | CA7 | P43166 | 2/20 | 0.45 |
| ▸ | HTR7 | P34969 | 3/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3355661 | 0.89 | MYC (0.47) | MYCTSHRACHENPC1CASP3 | |
| SCHEMBL1133067 | 0.88 | MYC (0.56) | MYCTSHRACHENPC1CASP3 | |
| SCHEMBL30354037 | 0.87 | ACHE (0.64) | TSHRACHENPC1CASP3RAB9A | |
| SCHEMBL30169568 | 0.87 | ACHE (0.64) | TSHRACHENPC1CASP3RAB9A | |
| SCHEMBL598761 | 0.87 | TSHR (0.53) | MYCTSHRACHENPC1CASP3 | |
| SCHEMBL197690 | 0.87 | ACHE (0.64) | TSHRACHENPC1CASP3RAB9A | |
| SCHEMBL28899579 | 0.85 | MYC (0.58) | MYCTSHRACHENPC1CASP3 | |
| SCHEMBL6564122 | 0.84 | ACHE (0.60) | TSHRACHENPC1CASP3RAB9A | |
| Lithium SCHEMBL31260773 | 0.84 | ACHE (0.60) | TSHRACHENPC1CASP3RAB9A | |
| Ammonia Solution, Strong SCHEMBL842431 | 0.84 | ACHE (0.60) | TSHRACHENPC1CASP3RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210322933-A1 | ZWITTERION-FUNCTIONALIZED COPOLYMER HOLLOW-FIBER MEMBRANES AND ASSOCIATED METHOD | CYTIVA SWEDEN AB (SE) | 2021-10-21 | — | — | US | disclosed |
| EP-3794056-A1 | ZWITTERION-FUNCTIONALIZED MULTICOMPONENT COPOLYMERS AND ASSOCIATED POLYMER BLENDS AND MEMBRANES | Cytiva Sweden AB (SE) | 2021-03-24 | — | — | EP | disclosed |
| US-20210079220-A1 | ZWITTERION-FUNCTIONALIZED MULTICOMPONENT COPOLYMERS AND ASSOCIATED POLYMER BLENDS AND MEMBRANES | CYTIVA SWEDEN AB (SE) | 2021-03-18 | — | — | US | disclosed |
| US-10851241-B2 | Zwitterion-functionalized multicomponent copolymers and associated polymer blends and membranes | CYTIVA SWEDEN AB (SE) | 2020-12-01 | — | — | US | disclosed |
| EP-3142778-B1 | ZWITTERION-FUNCTIONALIZED BLOCK COPOLYMER MEMBRANES AND ASSOCIATED BLOCK COPOLYMER COMPOSITION | GEN ELECTRIC (US) | 2019-01-30 | — | — | EP | disclosed |
| EP-3383523-A1 | ZWITTERIONIC SULFONE POLYMER FLAT SHEET MEMBRANE | General Electric Company (US) | 2018-10-10 | — | — | EP | disclosed |
| EP-3383524-A1 | ZWITTERIONIC SULFONE POLYMER BLEND AND HOLLOW-FIBER MEMBRANE | General Electric Company (US) | 2018-10-10 | — | — | EP | disclosed |
| US-20180258285-A1 | ZWITTERION-FUNCTIONALIZED MULTICOMPONENT COPOLYMERS AND ASSOCIATED POLYMER BLENDS AND MEMBRANES | GE HEALTHCARE BIO-SCIENCE AB (SE) | 2018-09-13 | — | — | US | disclosed |
| EP-3221036-A1 | ZWITTERION-FUNCTIONALIZED COPOLYMER HOLLOW-FIBER MEMBRANES AND ASSOCIATED METHOD | General Electric Company (US) | 2017-09-27 | — | — | EP | disclosed |
| WO-2017096140-A1 | ZWITTERIONIC SULFONE POLYMER BLEND AND HOLLOW-FIBER MEMBRANE | GENERAL ELECTRIC COMPANY (US) | 2017-06-08 | — | — | WO | disclosed |
| US-20080312349-A1 | METHOD OF MAKING AND USING MEMBRANE | GENERAL ELECTRIC COMPANY (US) | 2008-12-18 | — | — | US | disclosed |
| US-20080203012-A1 | MEMBRANE, APPARATUS, AND ASSOCIATED METHOD | GENERAL ELECTRIC COMPANY (US) | 2008-08-28 | — | — | US | disclosed |
| US-20080207822-A1 | COMPOSITION AND ASSOCIATED METHOD | GENERAL ELECTRIC COMPANY (US) | 2008-08-28 | — | — | US | disclosed |
| WO-2008103599-A2 | COMPOSITION, ITS USE IN THE PREPARATION OF MEMBRANES, AND SYSTEMS COMPRISING THE MEMBRANES | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2008-08-28 | — | — | WO | disclosed |
| US-20080142418-A1 | FUNCTIONAL POLYARYLETHERS | GENERAL ELECTRIC COMPANY (US) | 2008-06-19 | — | — | US | disclosed |
| US-20080142429-A1 | FUNCTIONAL POLYARYLETHERS | GENERAL ELECTRIC COMPANY (US) | 2008-06-19 | — | — | US | disclosed |
| US-20080142443-A1 | POLYARYLETHER MEMBRANES | GENERAL ELECTRIC (US) | 2008-06-19 | — | — | US | disclosed |
| US-20080142442-A1 | hollow fiber modules comprising blends of polyphenylene ethers block polymers and polyvinylpyrrolidone, used for blood dialysis and filtration | GENERAL ELECTRIC (US) | 2008-06-19 | — | — | US | disclosed |
| WO-2008073536-A1 | FUNCTIONAL POLYARYLETHERS | GENERAL ELECTRIC COMPANY (US) | 2008-06-19 | — | — | WO | disclosed |
| WO-2008073537-A1 | FUNCTIONAL POLYARYLETERS | GENERAL ELECTRIC COMPANY (US) | 2008-06-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080142429-A1 | FUNCTIONAL POLYARYLETHERS | CBR3, NR2E3, HRH4 | MYC 1940/4885TSHR 181/4885ACHE 4550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.